TScan Therapeutics Announces Pricing of $140 Million Public Offering

k2hv news

May 26

Written By MacDougall Creative

MacDougall Creative https://www.macbiocom.com

Elevation Oncology Announces Pricing of $50 Million Public Offering

Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease